BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 18166995)

  • 1. Photons or protons: precision radiotherapy of lung cancer.
    Auberger T; Seydl K; Futschek T; Sztankay A; Sweeney RA; Lukas P
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():3-6. PubMed ID: 18166995
    [No Abstract]   [Full Text] [Related]  

  • 2. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
    Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
    St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
    Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
    Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases.
    Yartsev S; Chen J; Yu E; Kron T; Rodrigues G; Coad T; Trenka K; Wong E; Bauman G; Dyk JV
    Radiother Oncol; 2006 Feb; 78(2):169-76. PubMed ID: 16413621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation treatment of lung cancer].
    Hayakawa K
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1211-4. PubMed ID: 17847583
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
    Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
    J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative radiotherapy for lung cancer: improvement in locoregional control using three-dimensional compared with two-dimensional technique.
    Masson-Côté L; Couture C; Fortin A; Dagnault A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):686-91. PubMed ID: 20646845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can protons improve SBRT for lung lesions? Dosimetric considerations.
    Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
    Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non small cell lung cancer].
    Leignel Argo D; Giraud P
    Cancer Radiother; 2010 Nov; 14 Suppl 1():S61-73. PubMed ID: 21129672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
    Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
    Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?
    Jeremic B
    Radiother Oncol; 2004 May; 71(2):123-5. PubMed ID: 15110444
    [No Abstract]   [Full Text] [Related]  

  • 16. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
    Radiology; 2000 Jun; 215 Suppl():1295-318. PubMed ID: 11037548
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
    Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
    Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curative radiotherapy of local advanced non-small-cell lung cancer. Eight years of experience from Odense].
    Hansen O; Paarup H; Sørensen P; Hansen KH; Werenberg KA
    Ugeskr Laeger; 2005 Sep; 167(37):3497-502. PubMed ID: 16159459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of forward planning with automated inverse planning for three-dimensional conformal radiotherapy of non-small cell lung cancer without IMRT.
    Mendes R; Lavrenkov K; Bedford JL; Henrys A; Ashley S; Brada M
    Radiother Oncol; 2006 Mar; 78(3):322-5. PubMed ID: 16564591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.